COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases

IntroductionPatients with immune-mediated glomerular diseases are considered at high risk for severe COVID-19 outcomes. However, conclusive evidence for this patient population is scarce.MethodsWe created a global registry and retrospectively collected clinical data of patients with COVID-19 and a p...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Philipp Gauckler, Jana S. Kesenheimer, Duvuru Geetha, Balazs Odler, Kathrin Eller, Timothee Laboux, Federico Alberici, Mattia Zappa, Natasha Chebotareva, Sergey Moiseev, Marco Bonilla, Kenar D. Jhaveri, Julie Oniszczuk, Vincent Audard, Denise Costa, Gianna Mastroianni-Kirsztajn, Annette Bruchfeld, Masahiro Muto, Martin Windpessl, Gert Mayer, Andreas Kronbichler
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2023-09-01
Edice:	Frontiers in Immunology
Témata:	coronavirus risk factor autoimmune disease kidney disease glomerulonephritis immunosuppression
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1228457/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!